A detailed history of Canal Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Canal Capital Management, LLC holds 5,240 shares of NVS stock, worth $519,283. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,240
Previous 5,184 1.08%
Holding current value
$519,283
Previous $551,000 9.26%
% of portfolio
0.1%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$106.13 - $120.89 $5,943 - $6,769
56 Added 1.08%
5,240 $602,000
Q4 2023

Jan 24, 2024

BUY
$92.27 - $101.54 $25,835 - $28,431
280 Added 5.71%
5,184 $523,000
Q3 2022

Oct 24, 2022

BUY
$74.61 - $87.26 $4,849 - $5,671
65 Added 1.34%
4,904 $373,000
Q1 2022

Apr 20, 2022

SELL
$80.11 - $90.62 $3.2 Million - $3.62 Million
-39,906 Reduced 89.19%
4,839 $425,000
Q4 2021

Jan 27, 2022

BUY
$79.7 - $88.13 $159,878 - $176,788
2,006 Added 4.69%
44,745 $3.91 Million
Q3 2021

Oct 14, 2021

SELL
$81.78 - $95.14 $18,073 - $21,025
-221 Reduced 0.51%
42,739 $3.5 Million
Q2 2021

Jul 14, 2021

BUY
$85.24 - $94.15 $271,404 - $299,773
3,184 Added 8.0%
42,960 $3.92 Million
Q1 2021

Apr 20, 2021

BUY
$83.5 - $98.47 $357,046 - $421,057
4,276 Added 12.05%
39,776 $3.4 Million
Q4 2020

Jan 27, 2021

BUY
$78.07 - $94.43 $39,659 - $47,970
508 Added 1.45%
35,500 $3.35 Million
Q3 2020

Oct 21, 2020

BUY
$82.14 - $91.0 $41,480 - $45,955
505 Added 1.46%
34,992 $3.04 Million
Q2 2020

Jul 22, 2020

BUY
$80.93 - $91.1 $28,972 - $32,613
358 Added 1.05%
34,487 $3.01 Million
Q1 2020

Apr 21, 2020

BUY
$70.67 - $99.01 $275,259 - $385,643
3,895 Added 12.88%
34,129 $2.81 Million
Q4 2019

Jan 21, 2020

BUY
$84.35 - $95.37 $105,859 - $119,689
1,255 Added 4.33%
30,234 $2.86 Million
Q3 2019

Oct 30, 2019

BUY
$85.54 - $94.26 $2.48 Million - $2.73 Million
28,951 Added 103396.43%
28,979 $2.52 Million
Q3 2019

Oct 28, 2019

SELL
$85.54 - $94.26 $2.45 Million - $2.7 Million
-28,644 Reduced 99.9%
28 $2.52 Million
Q2 2019

Jul 31, 2019

BUY
$75.4 - $92.8 $136,021 - $167,411
1,804 Added 6.71%
28,672 $2.62 Million
Q1 2019

May 03, 2019

BUY
$75.32 - $86.15 $21,918 - $25,069
291 Added 1.09%
26,868 $2.58 Million
Q4 2018

Feb 05, 2019

BUY
$73.66 - $82.02 $65,557 - $72,997
890 Added 3.46%
26,577 $2.28 Million
Q3 2018

Oct 17, 2018

BUY
$66.94 - $77.43 $61,116 - $70,693
913 Added 3.69%
25,687 $2.21 Million
Q2 2018

Aug 01, 2018

BUY
$64.91 - $73.36 $59,976 - $67,784
924 Added 3.87%
24,774 $1.87 Million
Q1 2018

Apr 27, 2018

SELL
$70.39 - $84.15 $53,214 - $63,617
-756 Reduced 3.07%
23,850 $1.93 Million
Q4 2017

Jan 24, 2018

BUY
$72.33 - $77.64 $234,132 - $251,320
3,237 Added 15.15%
24,606 $2.07 Million
Q3 2017

Oct 20, 2017

BUY
$74.14 - $77.27 $1.58 Million - $1.65 Million
21,369
21,369 $1.84 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Canal Capital Management, LLC Portfolio

Follow Canal Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canal Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canal Capital Management, LLC with notifications on news.